These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11647670)
1. How a corporate feud doomed human trials of promising therapy. Richards B Wall St J (East Ed); 1999 Aug; ():A1, A6. PubMed ID: 11647670 [No Abstract] [Full Text] [Related]
2. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986. Bulleit TN J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568 [No Abstract] [Full Text] [Related]
3. In business to treat cancer. Henig RM N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805 [No Abstract] [Full Text] [Related]
4. Medical insurance payments and patients involved in research. Holder AR IRB; 1994; 16(1-2):19-22. PubMed ID: 11652323 [No Abstract] [Full Text] [Related]
5. Baboon-to-human transplants: should we proceed? Arnold RM; Dresser R; Hefner P; Offner SK Mak Rounds Health Faith Ethics; 1995 Oct; 1(3):1, 3-4, 8. PubMed ID: 11653222 [No Abstract] [Full Text] [Related]
6. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related]
8. Who should rightfully decide whether a medical treatment necessarily incurred should be excluded from coverage under a health insurance policy provision which excludes from coverage "experimental" medical treatments? Fisfis BA Duquesne Law Rev; 1993; 31(4):777-800. PubMed ID: 11652669 [No Abstract] [Full Text] [Related]
9. Business thrives on unproven care, leaving science behind: a special report. Kolata G; Eichenwald K N Y Times Web; 1999 Oct; ():A1, A40-41. PubMed ID: 11647705 [No Abstract] [Full Text] [Related]
10. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
11. Gene dream fades away. Coghlan A New Sci; 1995 Nov; 148(2005):14-5. PubMed ID: 11656474 [No Abstract] [Full Text] [Related]
12. Taking the profit out of biomedical research tools. Flores MA Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252 [TBL] [Abstract][Full Text] [Related]
14. The sex-bias myth in medicine. Kadar AG Atl Mon; 1994 Aug; 274(2):66-70. PubMed ID: 11659876 [No Abstract] [Full Text] [Related]
15. Squabbling all the way to the genebank. Kleiner K New Sci; 1994 Nov; 144(1953):14-5. PubMed ID: 11656411 [No Abstract] [Full Text] [Related]
16. The price of profit. Coghlan A New Sci; 1998 May; 158(2134):20-1. PubMed ID: 11660513 [No Abstract] [Full Text] [Related]
17. FDA's new rule on treatment use and sale of investigational new drugs. Levine RJ IRB; 1987; 9(4):1-4. PubMed ID: 11649946 [No Abstract] [Full Text] [Related]
19. Biotechnology: can a new technology survive? Withers WW; Kenworthy PG St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845 [No Abstract] [Full Text] [Related]
20. Beyond Animal Legal Defense Fund v. Quigg: the controversy over transgenic animal patents continues. Hecht EJ Am Univ Law Rev; 1992; 41(3):1023-74. PubMed ID: 11652629 [No Abstract] [Full Text] [Related] [Next] [New Search]